Jim Simons Renaissance Technologies
Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$798M |
| 2 |
Netflix
NFLX
|
+$608M |
| 3 |
UnitedHealth
UNH
|
+$517M |
| 4 |
Apple
AAPL
|
+$461M |
| 5 |
GE Vernova
GEV
|
+$296M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Broadcom
AVGO
|
+$527M |
| 2 |
Alphabet (Google) Class A
GOOGL
|
+$372M |
| 3 |
Meta Platforms (Facebook)
META
|
+$362M |
| 4 |
Advanced Micro Devices
AMD
|
+$328M |
| 5 |
Palantir
PLTR
|
+$327M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.57% |
| 2 | Healthcare | 15.8% |
| 3 | Consumer Discretionary | 12.38% |
| 4 | Financials | 11.53% |
| 5 | Industrials | 8.92% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3326
Motorsport Games
MSGM
$18.7M
| $84.7K | ﹤0.01% |
+29,200
| New | +$69.2K |
|
3327
Skillful Craftsman
EDTK
$14.1M
| $83.7K | ﹤0.01% |
96,700
-13,900
| -13% | -$13.4K |
|
|
RBOT
3328
DELISTED
Vicarious Surgical
RBOT
| $83.5K | ﹤0.01% |
11,134
-1,500
| -12% | -$10.9K |
|
3329
KALA BIO
KALA
$17.9M
| $82.8K | ﹤0.01% |
+348
| New | +$67.9K |
|
3330
CVRx
CVRX
$78.3M
| $82.3K | ﹤0.01% |
+14,000
| New | +$96.6K |
|
|
GRCE
3331
Grace Therapeutics
GRCE
$43.5M
| $82K | ﹤0.01% |
27,625
-14,556
| -35% | -$38.7K |
|
3332
VistaGen Therapeutics
VTGN
$11.8M
| $81K | ﹤0.01% |
40,500
+15,700
| +63% | +$35.7K |
|
|
YQ
3333
17 Education & Technology Group
YQ
$23.2M
| $80.7K | ﹤0.01% |
36,830
+15,600
| +73% | +$30.2K |
|
3334
Coya Therapeutics
COYA
$110M
| $80.5K | ﹤0.01% |
14,000
+1,800
| +15% | +$10.4K |
|
|
IMDX
3335
Insight Molecular Diagnostics
IMDX
$121M
| $78.8K | ﹤0.01% |
+26,100
| New | +$78.9K |
|
|
SBFM
3336
Sunshine Biopharma
SBFM
$2.85M
| $77.9K | ﹤0.01% |
+5,409
| New | +$79K |
|
3337
ClearOne Inc
CLRO
$15.2M
| $77.3K | ﹤0.01% |
13,447
-1,081
| -7% | -$7.52K |
|
|
SOHO
3338
DELISTED
Sotherly Hotels
SOHO
| $76.7K | ﹤0.01% |
80,714
+200
| +0.2% | +$158 |
|
3339
Alto Neuroscience
ANRO
$1.26B
| $76.3K | ﹤0.01% |
+34,700
| New | +$82.6K |
|
3340
Urban One Class A
UONE
$23.5M
| $75.5K | ﹤0.01% |
4,720
+10
| +0.2% | +$155 |
|
|
PCLA
3341
PicoCELA Inc
PCLA
$61M
| $74K | ﹤0.01% |
+1,523
| New | +$34K |
|
3342
Armata Pharmaceuticals
ARMP
$177M
| $73.9K | ﹤0.01% |
38,896
+300
| +0.8% | +$486 |
|
3343
Elutia
ELUT
$38M
| $73.3K | ﹤0.01% |
37,016
-700
| -2% | -$1.42K |
|
3344
Wrap Technologies
WRAP
$97.4M
| $73K | ﹤0.01% |
+46,800
| New | +$70.5K |
|
|
LONA
3345
LeonaBio Inc
LONA
$73.9M
| $72.8K | ﹤0.01% |
24,100
+2,200
| +10% | +$6.23K |
|
3346
Performance Shipping
PSHG
$21.5M
| $72.8K | ﹤0.01% |
41,584
+13,184
| +46% | +$20.7K |
|
|
SOGP
3347
Sound Group
SOGP
$48.1M
| $72K | ﹤0.01% |
15,158
| – | – |
|
|
INCR
3348
Intercure
INCR
$54.9M
| $71.9K | ﹤0.01% |
48,900
+500
| +1% | +$739 |
|
3349
Atlantic American Corp
AAME
$29M
| $71.1K | ﹤0.01% |
33,400
+300
| +0.9% | +$502 |
|
3350
Grove Collaborative
GROV
$44M
| $70.8K | ﹤0.01% |
61,600
+5,200
| +9% | +$6.15K |
|
Similar funds
Jim Simons's Q2 2025 Portfolio in Review
As of Q2 2025, Jim Simons held 4,018 positions worth $75.2B, up 14% from $66.1B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
Jim Simons's Q2 2025 filing shows 612 new, 1,577 increased, 1,314 reduced and 496 closed positions. Its largest new stake was UnitedHealth: 1,352,129 shares worth $422M. The largest sale was Broadcom, an estimated $527M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 17% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Jim Simons's largest Q2 2025 buy was UnitedHealth: 1,352,129 shares worth $422M.
- Jim Simons added most to NVIDIA in Q2 2025, an estimated $798M increase.
- Jim Simons's biggest Q2 2025 reduction was Broadcom, cutting an estimated $527M.
- Jim Simons fully exited Advanced Micro Devices in Q2 2025, selling an estimated $328M.
- Jim Simons's ten largest holdings make up 12% of its $75.2B portfolio in Q2 2025.
- Jim Simons opened 612 new positions and closed 496 in Q2 2025.
- Jim Simons's portfolio value rose 14% quarter-over-quarter to $75.2B.
Based on Renaissance Technologies's 13F filing for Q2 2025, filed 13 Aug 2025.